As analysts forecast an upside of 12% for the Vanguard S&P Small-Cap 600 Value ETF (VIOV), the implied analyst target price for the ETF stands at $96.23 per unit, compared to its current trading price of $86.10 per unit. This analysis paints a favorable picture for investors, showing an anticipated increase in value for the ETF based on the future performance of its underlying holdings.
Among VIOV’s underlying holdings, Harmony Biosciences Holdings Inc (HRMY), TTM Technologies Inc (TTMI), and CoreCivic Inc (CXW) have notably positive projections. For instance, HRMY has an average analyst target price of $41.89 per share, reflecting a 23.89% increase from its recent trading price of $33.81 per share. Similarly, TTMI has an anticipated 22.60% upside from its recent share price of $15.65, with an average analyst target price of $19.19 per share. Additionally, analysts are expecting CXW to reach a target price of $17.75 per share, signifying a 21.58% increase from its recent price of $14.60 per share.
Investors can navigate these projections more effectively by examining the twelve-month price history chart comparing the stock performance of HRMY, TTMI, and CXW:
Furthermore, a summary table of the current analyst target prices for VIOV and its underlying holdings is as follows:
| Name | Symbol | Recent Price | Avg. Analyst 12-Mo. Target | % Upside to Target |
|---|---|---|---|---|
| Vanguard S&P Small-Cap 600 Value ETF | VIOV | $86.10 | $96.23 | 11.76% |
| Harmony Biosciences Holdings Inc | HRMY | $33.81 | $41.89 | 23.89% |
| TTM Technologies Inc | TTMI | $15.65 | $19.19 | 22.60% |
| CoreCivic Inc | CXW | $14.60 | $17.75 | 21.58% |
It’s essential for investors to critically assess whether these analyst targets are justifiable or overly optimistic. Are the analysts accurately reflecting recent company and industry developments, or are they working with outdated information? While a high price target relative to a stock’s trading price could signal optimism about the future, it may also foreshadow potential target price downgrades if the targets are outdated remnants of the past. No matter the outcome, investors can benefit from conducting thorough research to make informed decisions.
Looking for potential growth opportunities, investors might want to explore the top ten ETFs with the most upside to analyst targets. In addition, it’s noteworthy to examine the top ten hedge funds holding BKI, the dividend growth rate of TER, and funds holding SSLJ.
Also see:
Top Ten Hedge Funds Holding BKI
TER Dividend Growth Rate
Funds Holding SSLJ
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
